Clough Capital Partners L P Bristol Myers Squibb CO Transaction History

Clough Capital Partners L P

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $1.02 Million - $1.13 Million	-16,000 Reduced 29.8%	37,700 $2.41 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $3.53 Million - $4 Million	53,700 New	53,700 $3.72 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $1.35 Million - $1.61 Million	-29,841 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $5.48 Million - $7.11 Million	-112,419 Reduced 79.02%	29,841 $1.55 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $242,836 - $273,900	-4,400 Reduced 3.0%	142,260 $8.83 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $666,996 - $831,336	13,200 Added 9.89%	146,660 $8.12 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $305,592 - $351,798	5,100 Added 3.97%	133,460 $8.44 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $4.05 Million - $4.42 Million	-67,600 Reduced 34.5%	128,360 $7.87 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $10.8 Million - $12.5 Million	195,960	195,960 $12.5 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.